<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report"><?DTDIdentifier.IdentifierValue -//ES//DTD journal article DTD version 5.6.0//EN//XML?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName art560.dtd?><?SourceDTD.Version 5.6.0?><?ConverterInfo.XSLTName elsevier2nlmx2.xsl?><?ConverterInfo.Version 1?><?origin publisher?><?FILEmeta_IDCR764 xml ?><?FILEmain xml ?><?FILEmain pdf ?><?FILEgr4 jpg ?><?FILEgr5 jpg ?><?FILEgr6 jpg ?><?FILEpl1 jpg ?><?FILEpl2 jpg ?><?FILEpl3 jpg ?><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">IDCases</journal-id><journal-id journal-id-type="iso-abbrev">IDCases</journal-id><journal-title-group><journal-title>IDCases</journal-title></journal-title-group><issn pub-type="epub">2214-2509</issn><publisher><publisher-name>Elsevier</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7232083</article-id><article-id pub-id-type="publisher-id">S2214-2509(20)30072-X</article-id><article-id pub-id-type="doi">10.1016/j.idcr.2020.e00764</article-id><article-id pub-id-type="publisher-id">e00764</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Chronic meningococcemia in a vertically HIV-infected adolescent</article-title></title-group><contrib-group><contrib contrib-type="author" id="aut0005"><name><surname>Cardona</surname><given-names>Rita S.B.</given-names></name><email>cardona.rita@gmail.com</email><xref rid="aff0005" ref-type="aff">a</xref><xref rid="cor0005" ref-type="corresp">&#x0204e;</xref></contrib><contrib contrib-type="author" id="aut0010"><name><surname>do Carmo</surname><given-names>Fabiana Bononi</given-names></name><email>carmofb@ig.com.br</email><xref rid="aff0005" ref-type="aff">a</xref></contrib><contrib contrib-type="author" id="aut0015"><name><surname>Beltr&#x000e3;o</surname><given-names>Suenia Vasconcelos</given-names></name><email>suenia.beltrao@terra.com.br</email><xref rid="aff0005" ref-type="aff">a</xref></contrib><contrib contrib-type="author" id="aut0020"><name><surname>Gouv&#x000ea;a</surname><given-names>A&#x000ed;da de F&#x000e1;tima T. Barbosa</given-names></name><email>aidagouvea@uol.com.br</email><xref rid="aff0005" ref-type="aff">a</xref></contrib><contrib contrib-type="author" id="aut0025"><name><surname>Salom&#x000e3;o</surname><given-names>Reinaldo</given-names></name><email>rsalomao@unifesp.br</email><xref rid="aff0010" ref-type="aff">b</xref></contrib><contrib contrib-type="author" id="aut0030"><name><surname>Succi</surname><given-names>Regina C&#x000e9;lia de Menezes</given-names></name><email>succi@picture.com.br</email><xref rid="aff0005" ref-type="aff">a</xref></contrib><contrib contrib-type="author" id="aut0035"><name><surname>Machado</surname><given-names>Daisy Maria</given-names></name><email>daisymachado@gmail.com</email><xref rid="aff0005" ref-type="aff">a</xref></contrib><aff id="aff0005"><label>a</label>Pediatric Infectious Disease Clinical Care Center of Federal University of S&#x000e3;o Paulo, Pedro de Toledo Street 924/928 Vila Clementino, Zip Code 04039-002, S&#x000e3;o Paulo, SP, Brazil</aff><aff id="aff0010"><label>b</label>Adult Infectious Disease Department of Universidade Federal de S&#x000e3;o Paulo, Rua Napole&#x000e3;o de Barros 715 Vila Clementino, Zip Code 04024-002, S&#x000e3;o Paulo, SP, Brazil</aff></contrib-group><author-notes><corresp id="cor0005"><label>&#x0204e;</label>Corresponding author at: Pedro de Toledo Street 924/928 Vila Clementino, Zip Code 04039-002, S&#x000e3;o Paulo, SP, Brazil. <email>cardona.rita@gmail.com</email></corresp></author-notes><pub-date pub-type="pmc-release"><day>21</day><month>4</month><year>2020</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="collection"><year>2020</year></pub-date><pub-date pub-type="epub"><day>21</day><month>4</month><year>2020</year></pub-date><volume>20</volume><elocation-id>e00764</elocation-id><history><date date-type="received"><day>30</day><month>3</month><year>2020</year></date><date date-type="accepted"><day>2</day><month>4</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2020 The Authors</copyright-statement><copyright-year>2020</copyright-year><license license-type="CC BY-NC-ND" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/"><license-p>This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).</license-p></license></permissions><abstract abstract-type="author-highlights" id="abs0005"><title>Highlights</title><p><list list-type="simple" id="lis0005"><list-item id="lsti0005"><p id="par0005">&#x02022; Chronic meningococcemia is a rare manifestation of meningococcal disease.</p></list-item><list-item id="lsti0010"><p id="par0010">&#x02022; Few cases of this presentation both in previously healthy and immunocompromised patients, such HIV patients.</p></list-item><list-item id="lsti0015"><p id="par0015">&#x02022; The association between <italic>Neisseria meningitidis</italic> infection and HIV infection is not yet well defined.</p></list-item></list></p></abstract><abstract id="abs0010"><p>Chronic meningococcemia is a rare manifestation of meningococcal disease, characterized by a period of more than one week of intermittent or continuous fever, arthralgia and skin lesions without meningitis. It can occur both in previously healthy and immunocompromised patients. The gold standard for the diagnosis is culture isolation of <italic>Neisseria meningitidis</italic> in sterile material. We describe a case of a vertically HIV-infected adolescent with chronic meningococcal disease.</p></abstract><kwd-group id="kwd0005"><title>Keywords</title><kwd>Chronic meningococcemia</kwd><kwd><italic>Neisseria meningitides</italic></kwd><kwd>HIV infection</kwd></kwd-group></article-meta></front><body><sec id="sec0005"><title>Introduction</title><p id="par0020">Meningococcal disease may present as meningococcal meningitis, meningococcal meningitis with meningococcemia, and isolated meningococcemia. It is a disease caused by the bacterium <italic>Neisseria meningitidis</italic>. Even though there are 12 bacterial serotypes, invasive meningococcal disease is associated with six, classified based on the polysaccharide capsule (A, B, C, W-135, X, Y) [<xref rid="bib0005" ref-type="bibr">1</xref>]. The bacterium colonizes the nasopharynx of asymptomatic carriers up to about 5&#x02013;10 % of the population, being transmitted from person to person by respiratory secretions [<xref rid="bib0010" ref-type="bibr">2</xref>].</p><p id="par0025">In Brazil, meningococcal disease is endemic with periodic outbreaks of epidemics in several municipalities. The incidence coefficients have remained stable in recent years, with approximately 1.8 cases per 100,000 inhabitants [<xref rid="bib0015" ref-type="bibr">3</xref>]. In S&#x000e3;o Paulo city, in 2018, 204 cases were confirmed, with 36 deaths, with incidence coefficient being 1.74 and mortality 0.31 [<xref rid="bib0020" ref-type="bibr">4</xref>]. The lethality of the disease in our country has been around 18&#x02013;20% in recent years, and it may achieve coefficients of almost 50 % in septic presentations [<xref rid="bib0015" ref-type="bibr">3</xref>]. Serotypes B and C cause disease predominantly in Europe and the Americas, being the most common in Brazil [<xref rid="bib0015" ref-type="bibr">3</xref>].</p><p id="par0030">Although the most common clinical manifestations are fever and acute and rapidly progressive petechial and/or purpuric rash, progressing to septic shock within a few hours, there are some chronic, initially more benign presentations, such as chronic meningococcemia [<xref rid="bib0025" ref-type="bibr">5</xref>]. This form represents less than 5% of all cases of meningococcemia, with incidence &#x0003c;0.05 cases per 100,000 inhabitants per year in developed countries [<xref rid="bib0030" ref-type="bibr">6</xref>]. It is a rare manifestation of meningococcal disease without meningitis, of prolonged course of more than one week, with intermittent or continuous fever, arthralgia and cutaneous vasculitis [<xref rid="bib0005" ref-type="bibr">1</xref>]. Few cases of this presentation have been reported, both in previously healthy and immunocompromised patients [<xref rid="bib0025" ref-type="bibr">5</xref>,<xref rid="bib0035" ref-type="bibr">7</xref>].</p><p id="par0035">A case of chronic meningococcemia diagnosed in a vertically infected adolescent with human immunodeficiency virus (HIV) infection will be described, providing a review of the literature on the topic. Its importance lies in the description of a rare disease with atypical manifestation, which is difficult to suspect, and which may be life-threatening if not diagnosed and treated promptly and adequately. This case report was approved by local ethics committee; the patient signed the consent form, with permission to disclose images.</p></sec><sec id="sec0010"><title>Clinical case</title><p id="par0040">Adolescent, 19 years old, male, vertically HIV-infected, followed up since 3 months of age at our Pediatric Infectious Disease Clinical Care Center. Not adherent to the antiretroviral treatment, he has presented several clinical intercurrences during his life. At the time of this event, there was significant viral replication (HIV viral load 87,802 copies/&#x003bc;L) and severe immunosuppression (CD4+ count 17 cells/&#x003bc;L).</p><p id="par0045">He came to our medical center with 5 days of prostration, epigastric pain, sparse petechiae, joint pain, ocular pain and conjunctival hyperemia. Fever at the beginning for three days. Initially, he sought another service and the laboratory tests performed detected leukocytosis 19,600/ul (81 % neutrophils), and thrombocytopenia 77,000/ul. He received intravenous hydration and was discharged with symptomatic medication. In our service, he was in good general condition, pale, presenting conjunctival hyperemia, some petechiae on the trunk and limbs, without other signs (see Pictures <xref rid="fig0005" ref-type="fig">1</xref><xref rid="fig0010" ref-type="fig">&#x02013;</xref><xref rid="fig0015" ref-type="fig">3</xref> ). Laboratory tests were performed: leukocytes 4330/ul (53 % neutrophils, 33 % lymphocytes) and improved thrombocytopenia 124,000/uL. As there is epidemiological conditions for arboviruses in our country, serology and blood viral research by polymerase chain reaction (PCR) were done for dengue, zika and chikungunya &#x02013; all tested negative; serology tested non-reactive for toxoplasmosis and syphilis; for cytomegalovirus serology tested IgG reagent IgM non-reactive. He received symptomatic treatment with partial clinical improvement, keeping skin lesions unchanged. At this time, he was afebrile.<fig id="fig0005"><label>Picture 1</label><caption><p>Right eye conjunctival hyperemia.</p></caption><alt-text id="at0050">Picture 1</alt-text><graphic xlink:href="pl1"/></fig><fig id="fig0010"><label>Picture 2</label><caption><p>Petechiae on the soles of the feet.</p></caption><alt-text id="at0055">Picture 2</alt-text><graphic xlink:href="pl2"/></fig><fig id="fig0015"><label>Picture 3</label><caption><p>Petechia on the arms.</p></caption><alt-text id="at0060">Picture 3</alt-text><graphic xlink:href="pl3"/></fig></p><p id="par0050">Sixteen days after the onset of symptoms, he presented a return of prostration, fever and disseminated hemorrhagic suffusions (see <xref rid="fig0020" ref-type="fig">Pictures 4 and 5</xref>, <xref rid="fig0020" ref-type="fig">Pictures 4 and 5</xref>). He was hospitalized in septic shock, and during the diagnostic investigation, two blood cultures were positive for <italic>Neisseria meningitidis</italic> C, eighteen days since disease onset.<fig id="fig0020"><label>Pictures 4 and 5</label><caption><p>Hemorrhagic suffusions on the limbs.</p></caption><alt-text id="at0065">Pictures 4 and 5</alt-text><graphic xlink:href="gr4"/><graphic xlink:href="gr5"/></fig></p><p id="par0055">He presented normal cerebrospinal fluid examination with negative bacterioscopy and culture. The patient evolved with acute respiratory distress syndrome and acute renal failure, requiring endotracheal intubation and hemodialysis. He was hospitalized for 46 days, received 10 days of ceftriaxone 2&#x0202f;g 12/12&#x0202f;h. During hospitalization, HIV viral load 382,863 copies/&#x003bc;L and CD4+ count 13 cells/&#x003bc;L. He progressively evolved with improvement, being discharged in good clinical conditions, receiving combined antiretroviral therapy.</p><p id="par0060">The vaccine card was checked, he had received two doses of the meningococcal conjugate vaccine C before this clinical complication: 15 years before with HIV viral load 146,000 copies/&#x003bc;L and CD4+ count 762 cells/&#x003bc;L and 3 years before with HIV viral load 130,214 copies/&#x003bc;L and CD4+ count 75 cells/&#x003bc;L.</p><p id="par0065">Currently, the patient presents good adherence to the antiretroviral medication, with an improvement in CD4+ cell count (445 cells/&#x003bc;L) and a decrease in viral load (155 copies/&#x003bc;L); he has cutaneous scars derived from meningococcal vasculitis (see <xref rid="fig0025" ref-type="fig">Picture 6</xref>)<fig id="fig0025"><label>Picture 6</label><caption><p>Cutaneous scars on the limbs.</p></caption><alt-text id="at0070">Picture 6</alt-text><graphic xlink:href="gr6"/></fig></p></sec><sec id="sec0015"><title>Discussion</title><p id="par0070">We describe a case of a vertically HIV-infected adolescent with chronic meningococcal disease.</p><p id="par0075">Chronic meningococcemia is a disease caused by the bacterium <italic>Neisseria meningitidis</italic>, characterized by a period of more than one week of intermittent or continuous fever, arthralgia and skin lesions without meningitis [<xref rid="bib0005" ref-type="bibr">1</xref>]. Initial erythema develops to petechiae and purpura due to dermal microvascular thrombosis and perivascular hemorrhage [<xref rid="bib0040" ref-type="bibr">8</xref>]. Other clinical manifestations may occur, such as myalgia, abdominal pain, weight loss, iritis, retinitis [<xref rid="bib0045" ref-type="bibr">9</xref>]. It may be a self-limiting disease, but meningitis and death may occur as late complications [<xref rid="bib0050" ref-type="bibr">10</xref>]. These manifestations mimic several other infections, namely arboviruses, which was a confounding factor in our patient, delaying the diagnosis.</p><p id="par0080">The gold standard diagnostic method is culture isolation of <italic>Neisseria meningitidis</italic> in sterile material [<xref rid="bib0055" ref-type="bibr">11</xref>].</p><p id="par0085">Even if the course seems to be self-limited, the fact that the patient may remain as an asymptomatic carrier and thus develop an invasive disease or spread the agent has tended to favor antimicrobial treatment [<xref rid="bib0060" ref-type="bibr">12</xref>]. The suggested treatment is based on the use of beta-lactams, namely 3rd generation cephalosporin, used in our patient [<xref rid="bib0005" ref-type="bibr">1</xref>,<xref rid="bib0030" ref-type="bibr">6</xref>].</p><p id="par0090">The reason why these less severe forms of the disease occur is unknown; the susceptibility of the host and the virulence of the bacterium are possible explanations [<xref rid="bib0005" ref-type="bibr">1</xref>,<xref rid="bib0065" ref-type="bibr">13</xref>]. Although there seems to be a greater association with serotype B [<xref rid="bib0005" ref-type="bibr">1</xref>], serotype C was isolated in our patient. The disease can occur in previously healthy individuals or with some immunodeficiency [<xref rid="bib0025" ref-type="bibr">5</xref>,<xref rid="bib0035" ref-type="bibr">7</xref>,<xref rid="bib0045" ref-type="bibr">9</xref>].</p><p id="par0095">After a literature review, we identified only four cases of chronic meningococcemia in horizontally HIV-infected adult patients since 1990, none with this serious evolution [<xref rid="bib0030" ref-type="bibr">6</xref>,<xref rid="bib0045" ref-type="bibr">9</xref>,<xref rid="bib0070" ref-type="bibr">14</xref>]. A recent study found a substantial increased risk of meningococcal disease among adults with HIV infection that met AIDS criteria; in this study they observed a similar clinical presentation and outcomes of meningococcal disease compared to those without HIV infection [<xref rid="bib0075" ref-type="bibr">15</xref>]. The increased relative risk observed for meningococcal disease was similar to those observed for HIV-infected individuals in New York City, South Africa and England, ranged from 3.4&#x02013;6.6 per 100,000 (relative risk&#x0202f;=&#x0202f;5&#x02013;13 compared with HIV-uninfected persons) [<xref rid="bib0075" ref-type="bibr">[15]</xref>, <xref rid="bib0080" ref-type="bibr">[16]</xref>, <xref rid="bib0085" ref-type="bibr">[17]</xref>, <xref rid="bib0090" ref-type="bibr">[18]</xref>]. Among HIV-infected persons, a low CD4 count or high viral load were associated with an increased risk [<xref rid="bib0085" ref-type="bibr">17</xref>]. Considering this increased risk, in 2016 the US Advisory Committees on Immunization Practices approved a recommendation for routine vaccination of HIV-infected person [<xref rid="bib0095" ref-type="bibr">19</xref>]. In Brazil, meningococcal conjugate vaccine type C is routinely recommended for HIV-infected patients.</p><p id="par0100">With this clinical case we intend to highlight the heterogeneity and low specificity of the symptoms that meningococcal disease may present, especially in immunocompromised hosts, leading to a possible diagnostic delay of a potentially fatal disease.</p><p id="par0105">The association between <italic>Neisseria meningitidis</italic> infection and HIV infection is not yet well defined. Due to the potential for progression and the risk of <italic>N. meningitidis</italic> transmission, a better understanding of the association between HIV infection and meningococcal disease is important to prevention strategies.</p></sec><sec id="sec0020"><title>Ethical approval</title><p id="par0110">Written informed consent was obtained from the patient for publication of this case report and accompanying images. This case report was approved by local ethics committee.</p></sec><sec id="sec0025"><title>Funding</title><p id="par0115">This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.</p></sec><sec id="sec00005"><title>CRediT authorship contribution statement</title><p id="par00005"><bold>Rita S.B. Cardona:</bold> Data curation, Formal analysis, Writing - original draft. <bold>Fabiana Bononi do Carmo:</bold> . <bold>Suenia Vasconcelos Beltr&#x000e3;o:</bold> . <bold>A&#x000ed;da de F&#x000e1;tima T. Barbosa Gouv&#x000ea;a:</bold> . <bold>Reinaldo Salom&#x000e3;o:</bold> . <bold>Regina C&#x000e9;lia de Menezes Succi:</bold> Supervision, Writing - review &#x00026; editing. <bold>Daisy Maria Machado:</bold> Conceptualization, Writing - review &#x00026; editing.</p></sec><sec sec-type="COI-statement"><title>Declaration of Competing Interest</title><p id="par0120">The authors have no conflict of interests, personal or financial, to declare.</p></sec></body><back><ref-list id="bibl0005"><title>References</title><ref id="bib0005"><label>1</label><element-citation publication-type="journal" id="sbref0005"><person-group person-group-type="author"><name><surname>Ferraz</surname><given-names>R.V.</given-names></name><name><surname>Ceia</surname><given-names>F.</given-names></name><name><surname>Duro</surname><given-names>R.</given-names></name><name><surname>Carvalho</surname><given-names>A.C.</given-names></name><name><surname>Andrade</surname><given-names>P.</given-names></name><name><surname>Silva</surname><given-names>S.</given-names></name></person-group><article-title>Chronic meningococcemia</article-title><source>Adv Infect Dis</source><volume>6</volume><year>2016</year><fpage>97</fpage><lpage>101</lpage><pub-id pub-id-type="doi">10.4236/aid.2016.63012</pub-id></element-citation></ref><ref id="bib0010"><label>2</label><element-citation publication-type="journal" id="sbref0010"><person-group person-group-type="author"><name><surname>Coureuil</surname><given-names>M.</given-names></name><name><surname>Join-Lambert</surname><given-names>O.</given-names></name><name><surname>L&#x000e9;cuyer</surname><given-names>H.</given-names></name><name><surname>Bourdoulous</surname><given-names>S.</given-names></name><name><surname>Marullo</surname><given-names>S.</given-names></name><name><surname>Nassif</surname><given-names>X.</given-names></name></person-group><article-title>Pathogenesis of meningococcemia</article-title><source>Cold Spring Harbor Perspect Med.</source><volume>3</volume><year>2013</year><object-id pub-id-type="publisher-id">a012393</object-id><pub-id pub-id-type="doi">10.1101/cshperspect.a012393</pub-id></element-citation></ref><ref id="bib0015"><label>3</label><element-citation publication-type="journal" id="sbref0015"><person-group person-group-type="author"><name><surname>Berezin</surname><given-names>E.</given-names></name></person-group><article-title>Epidemiologia da infec&#x000e7;&#x000e3;o meningoc&#x000f3;cica</article-title><source>Doen&#x000e7;a Meningoc&#x000f3;cica</source><volume>1</volume><year>2015</year><fpage>3</fpage><lpage>7</lpage></element-citation></ref><ref id="bib0020"><label>4</label><element-citation publication-type="book" id="sbref0020"><person-group person-group-type="author"><name><surname>S&#x000e3;o Paulo</surname></name></person-group><chapter-title>Vigil&#x000e2;ncia em Sa&#x000fa;de da Prefeitura de S&#x000e3;o Paulo. S&#x000e9;rie hist&#x000f3;rica de casos e &#x000f3;bitos confirmados de doen&#x000e7;a meningoc&#x000f3;cica, coeficientes de incid&#x000ea;ncia e mortalidade por 100.000 habitantes, residentes no Munic&#x000ed;pio de S&#x000e3;o Paulo</chapter-title><year>2007</year><comment>a 2019. <ext-link ext-link-type="uri" xlink:href="https://www.prefeitura.sp.gov.br/cidade/secretarias/saude/vigilancia_em_saude/index.php?p=244832/" id="intr0005">https://www.prefeitura.sp.gov.br/cidade/secretarias/saude/vigilancia_em_saude/index.php?p=244832/</ext-link>; 2019 [accessed 16 june 2019]</comment></element-citation></ref><ref id="bib0025"><label>5</label><element-citation publication-type="journal" id="sbref0025"><person-group person-group-type="author"><name><surname>Brouwer</surname><given-names>M.C.</given-names></name><name><surname>Spanjaard</surname><given-names>L.</given-names></name><name><surname>Prins</surname><given-names>J.M.</given-names></name><name><surname>van der Ley</surname><given-names>P.</given-names></name><name><surname>van de Beek</surname><given-names>D.</given-names></name><name><surname>van der Ende</surname><given-names>A.</given-names></name></person-group><article-title>Association of chronic meningococcemia with infection by meningococci with underacylate dlipopolysaccharide</article-title><source>J Infect</source><volume>62</volume><year>2011</year><fpage>479</fpage><lpage>483</lpage><pub-id pub-id-type="doi">10.1016/j.jinf.2011.03.010</pub-id><pub-id pub-id-type="pmid">21459106</pub-id></element-citation></ref><ref id="bib0030"><label>6</label><element-citation publication-type="journal" id="sbref0030"><person-group person-group-type="author"><name><surname>Lef&#x000e8;vre</surname><given-names>B.</given-names></name><name><surname>Poinsignon</surname><given-names>Y.</given-names></name><name><surname>Piau</surname><given-names>C.</given-names></name><name><surname>Javaugue</surname><given-names>F.C.</given-names></name><name><surname>Talarmin</surname><given-names>J.P.</given-names></name><name><surname>Lefebvre</surname><given-names>M.</given-names></name></person-group><article-title>Chronic meningococcemia: a report of 26 cases and literature review</article-title><source>Infection</source><volume>47</volume><issue>2</issue><year>2019</year><fpage>285</fpage><lpage>288</lpage><pub-id pub-id-type="doi">10.1007/s15010-018-1238-x</pub-id><pub-id pub-id-type="pmid">30341638</pub-id></element-citation></ref><ref id="bib0035"><label>7</label><element-citation publication-type="journal" id="sbref0035"><person-group person-group-type="author"><name><surname>Nielsen</surname><given-names>H.E.</given-names></name><name><surname>Koch</surname><given-names>C.</given-names></name><name><surname>Mansa</surname><given-names>B.</given-names></name><name><surname>Magnussen</surname><given-names>P.</given-names></name><name><surname>Bergmann</surname><given-names>O.J.</given-names></name></person-group><article-title>Complement and immunoglobulin studies in 15 cases of chronic meningococcemia: properdin deficiency and hypoimmunoglobulinemia</article-title><source>Scand J Infect Dis</source><volume>22</volume><issue>1</issue><year>1990</year><fpage>31</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.3109/00365549009023116</pub-id><pub-id pub-id-type="pmid">2320962</pub-id></element-citation></ref><ref id="bib0040"><label>8</label><element-citation publication-type="journal" id="sbref0040"><person-group person-group-type="author"><name><surname>Hazelzet</surname><given-names>J.A.</given-names></name></person-group><article-title>Diagnosing meningococcemia as a cause of sepsis</article-title><source>Pediatr Crit Care Med</source><volume>6</volume><issue>3</issue><year>2005</year><fpage>S50</fpage><lpage>4</lpage><pub-id pub-id-type="doi">10.1097/01.PCC.0000161947.57506.D6</pub-id><pub-id pub-id-type="pmid">15857559</pub-id></element-citation></ref><ref id="bib0045"><label>9</label><element-citation publication-type="journal" id="sbref0045"><person-group person-group-type="author"><name><surname>Assier</surname><given-names>H.</given-names></name><name><surname>Chosidow</surname><given-names>O.</given-names></name><name><surname>Rekacewicz</surname><given-names>I.</given-names></name><name><surname>Lionnet</surname><given-names>F.</given-names></name><name><surname>Pipau</surname><given-names>F.G.</given-names></name><name><surname>Riou</surname><given-names>J.Y.</given-names></name></person-group><article-title>Chronic meningococcemia in acquired immunodeficiency</article-title><source>J Am Acad Dermatol</source><volume>29</volume><issue>5</issue><year>1993</year><fpage>793</fpage><lpage>794</lpage><pub-id pub-id-type="doi">10.1016/s0190-9622(08)81709-4</pub-id><pub-id pub-id-type="pmid">8227560</pub-id></element-citation></ref><ref id="bib0050"><label>10</label><element-citation publication-type="journal" id="sbref0050"><person-group person-group-type="author"><name><surname>Harwood</surname><given-names>C.A.</given-names></name><name><surname>Stevens</surname><given-names>J.C.</given-names></name><name><surname>Orton</surname><given-names>D.</given-names></name><name><surname>Bull</surname><given-names>R.C.</given-names></name><name><surname>Paige</surname><given-names>D.</given-names></name><name><surname>Lessing</surname><given-names>M.P.</given-names></name></person-group><article-title>Chronic meningococcaemia: a forgotten meningococcal disease</article-title><source>Br J Dermatol</source><volume>153</volume><issue>3</issue><year>2005</year><fpage>669</fpage><lpage>671</lpage><comment>https://doi.org/10.111/j.1365-2133.2005.06771.x</comment><pub-id pub-id-type="pmid">16120166</pub-id></element-citation></ref><ref id="bib0055"><label>11</label><element-citation publication-type="book" id="sbref0055"><person-group person-group-type="author"><name><surname>Centers for Disease Control</surname></name></person-group><chapter-title>Meningococcal disease</chapter-title><source>Centers for disease control and prevention epidemiology and prevention of vaccine-preventable diseases</source><edition>13th edition</edition><year>2015</year></element-citation></ref><ref id="bib0060"><label>12</label><element-citation publication-type="journal" id="sbref0060"><person-group person-group-type="author"><name><surname>Prista-Le&#x000e3;o</surname><given-names>B.</given-names></name><name><surname>Almeida</surname><given-names>F.</given-names></name><name><surname>Carvalho</surname><given-names>A.C.</given-names></name><name><surname>Silva</surname><given-names>S.</given-names></name><name><surname>Sarmento</surname><given-names>A.</given-names></name></person-group><article-title>Chronic meningococcemia</article-title><source>IDCases</source><volume>15</volume><year>2019</year><fpage>1</fpage><lpage>3</lpage><pub-id pub-id-type="doi">10.1016/j.idcr.2019.e00502</pub-id></element-citation></ref><ref id="bib0065"><label>13</label><element-citation publication-type="journal" id="sbref0065"><person-group person-group-type="author"><name><surname>Dupin</surname><given-names>N.</given-names></name><name><surname>Lecuyer</surname><given-names>H.</given-names></name><name><surname>Carlotti</surname><given-names>A.</given-names></name><name><surname>Poyart</surname><given-names>C.</given-names></name><name><surname>Coureuil</surname><given-names>M.</given-names></name><name><surname>Chanal</surname><given-names>J.</given-names></name></person-group><article-title>Chronic meningococcemia cutaneous lesions involve meningococcal perivascular invasion through the remodeling of endothelial barriers</article-title><source>Clin Infect Dis</source><volume>54</volume><issue>8</issue><year>2012</year><fpage>1162</fpage><lpage>1165</lpage><pub-id pub-id-type="doi">10.1093/cid/cis120</pub-id><pub-id pub-id-type="pmid">22412064</pub-id></element-citation></ref><ref id="bib0070"><label>14</label><element-citation publication-type="journal" id="sbref0070"><person-group person-group-type="author"><name><surname>Aguado</surname><given-names>J.M.</given-names></name><name><surname>Vada</surname><given-names>J.</given-names></name><name><surname>Zu&#x000f1;iga</surname><given-names>M.</given-names></name></person-group><article-title>Meningococcemia, an undescribed cause of community-acquired bacteremia in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex</article-title><source>Am J Med</source><volume>88</volume><year>1990</year><fpage>314</fpage><pub-id pub-id-type="doi">10.1016/0002-9343(90)90163-8</pub-id></element-citation></ref><ref id="bib0075"><label>15</label><element-citation publication-type="journal" id="sbref0075"><person-group person-group-type="author"><name><surname>Harris</surname><given-names>C.M.</given-names></name><name><surname>Wu</surname><given-names>H.M.</given-names></name><name><surname>Li</surname><given-names>J.</given-names></name><name><surname>Hall</surname><given-names>H.I.</given-names></name><name><surname>Lee</surname><given-names>A.</given-names></name><name><surname>Zell</surname><given-names>E.</given-names></name></person-group><article-title>Meningococcal disease in patients with human immunodeficiency virus infection: a review of cases reported through active surveillance in the United States, 2000-2008</article-title><source>Open Forum Infect Dis</source><volume>3</volume><issue>4</issue><year>2016</year><fpage>1</fpage><lpage>5</lpage><pub-id pub-id-type="doi">10.1093/ofid/ofw226</pub-id></element-citation></ref><ref id="bib0080"><label>16</label><element-citation publication-type="journal" id="sbref0080"><person-group person-group-type="author"><name><surname>Cohen</surname><given-names>C.</given-names></name><name><surname>Singh</surname><given-names>E.</given-names></name><name><surname>Wu</surname><given-names>H.M.</given-names></name><name><surname>Martin</surname><given-names>S.</given-names></name><name><surname>de Gouveia</surname><given-names>L.</given-names></name><name><surname>Klugman</surname><given-names>K.P.</given-names></name></person-group><article-title>Increased incidence of meningococcal disease in HIV-infected individuals associated with higher case-fatality ratios in South Africa</article-title><source>AIDS</source><volume>24</volume><issue>9</issue><year>2010</year><fpage>1351</fpage><lpage>1360</lpage><pub-id pub-id-type="doi">10.1097/QAD.0b013e32833a2520</pub-id><pub-id pub-id-type="pmid">20559040</pub-id></element-citation></ref><ref id="bib0085"><label>17</label><element-citation publication-type="journal" id="sbref0085"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>L.</given-names></name><name><surname>Arakaki</surname><given-names>L.</given-names></name><name><surname>Ramautar</surname><given-names>A.</given-names></name><name><surname>Bodach</surname><given-names>S.</given-names></name><name><surname>Braunstein</surname><given-names>S.L.</given-names></name><name><surname>Kennedy</surname><given-names>J.</given-names></name></person-group><article-title>Elevated risk for invasive meningococcal disease among persons with HIV</article-title><source>Ann Intern Med</source><volume>160</volume><issue>1</issue><year>2014</year><fpage>30</fpage><lpage>37</lpage><pub-id pub-id-type="doi">10.7326/0003-4819-160-1-201401070-00731</pub-id><pub-id pub-id-type="pmid">24166695</pub-id></element-citation></ref><ref id="bib0090"><label>18</label><element-citation publication-type="journal" id="sbref0090"><person-group person-group-type="author"><name><surname>Simmons</surname><given-names>R.D.</given-names></name><name><surname>Kirwan</surname><given-names>P.</given-names></name><name><surname>Beebeejaun</surname><given-names>K.</given-names></name><name><surname>Riordan</surname><given-names>A.</given-names></name><name><surname>Borrow</surname><given-names>R.</given-names></name><name><surname>Ramsay</surname><given-names>M.E.</given-names></name></person-group><article-title>Risk of invasive meningococcal disease in children and adults with HIV in England: a population-based cohort study</article-title><source>BMC Med</source><volume>13</volume><year>2015</year><fpage>297</fpage><pub-id pub-id-type="doi">10.1186/s12916-015-0538-6</pub-id><pub-id pub-id-type="pmid">26654248</pub-id></element-citation></ref><ref id="bib0095"><label>19</label><element-citation publication-type="journal" id="sbref0095"><person-group person-group-type="author"><name><surname>MacNeil</surname><given-names>J.R.</given-names></name><name><surname>Rubin</surname><given-names>L.G.</given-names></name><name><surname>Patton</surname><given-names>M.</given-names></name><name><surname>Ortega-Sanchez</surname><given-names>I.R.</given-names></name></person-group><article-title>MartinSW. Recommendations for use of meningococcal conjugate vaccines in HIV-infected persons&#x02014;Advisory Committee on Immunization Practices, 2016</article-title><source>MMWR Morb Mortal Wkly Rep</source><volume>65</volume><issue>43</issue><year>2016</year><fpage>1189</fpage><lpage>1194</lpage><pub-id pub-id-type="doi">10.15585/mmwr.mm6543a3</pub-id><pub-id pub-id-type="pmid">27811836</pub-id></element-citation></ref></ref-list><ack id="ack0005"><title>Acknowledgement</title><p>The authors would like to acknowledge the entire multidisciplinary team that took care of the patient during hospitalization.</p></ack></back></article>